Symptom Experience and Symptom Distress in Patients with Malignant Brain Tumor Treated with Proton Therapy: A Five-year Follow-up Study

Overview

Journal Tech Innov Patient Support Radiat Oncol

Date 2024 Sep 16

PMID 39280778

Authors

Kristin Kunni

Ulrica Langegard

Emma Ohlsson-Nevo

Ingrid Kristensen

Katarina Sjovall

Per Fesse

Linda Akeflo

Karin Ahlberg

Per Fransson

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Since patients with primary brain tumor are expected to become long-term survivors, the prevention of long-term treatment-induced side effects is particularly important. This study aimed to explore whether symptom experience and symptom distress change over five years in adults with primary brain tumors treated with proton therapy. An additional aim was to explore whether symptom experience and symptom distress correlate.

Materials And Methods: The study had a longitudinal observational design. Adult (≥18 years) patients (n = 170) with primary brain tumors treated with proton therapy were followed over five years. Symptom experience and symptom distress were evaluated using the patient-reported Radiotherapy-Related Symptom Assessment Scale. Data from baseline, 1, 12, and 60 months were analyzed using non-parametric tests.

Results: Of the 170 patients, the levels of symptoms and symptom distress were low. Fatigue increased at 1 (p=0.005) and 12 months (p=0.025) and was the most frequent symptom from baseline to 60 months' follow-up. Cognitive impairment increased at 12 (p=0.027) and 60 months (p<0.001) and was the most distressing symptom at 60 months' follow-up. There were significant, moderate to strong, correlations at all time points between symptom experience and symptom distress of fatigue, insomnia, pain, dyspnea, cognitive impairment, worry, anxiety, nausea, sadness, constipation, and skin reactions.

Conclusion: Symptom experience and symptom distress changed in intensity over time with cognitive impairment as the most distressing symptom at 60 months. Future research should focus on identifying effective interventions aimed at alleviating these symptoms and reducing symptom distress for this vulnerable group of patients.

References

Coomans M, van der Linden S, Gehring K, Taphoorn M . Treatment of cognitive deficits in brain tumour patients: current status and future directions. Curr Opin Oncol. 2019; 31(6):540-547. PMC: 6824580. DOI: 10.1097/CCO.0000000000000581. View

Armstrong T, Dirven L, Arons D, Bates A, Chang S, Coens C . Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report. Lancet Oncol. 2020; 21(2):e97-e103. DOI: 10.1016/S1470-2045(19)30796-X. View

Mollerberg M, Langegard U, Johansson B, Ohlsson-Nevo E, Fransson P, Ahlberg K . Evaluation of skin reactions during proton beam radiotherapy - Patient-reported versus clinician-reported. Tech Innov Patient Support Radiat Oncol. 2021; 19:11-17. PMC: 8233127. DOI: 10.1016/j.tipsro.2021.05.001. View

IJzerman-Korevaar M, Snijders T, de Graeff A, Teunissen S, de Vos F . Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review. J Neurooncol. 2018; 140(3):485-496. PMC: 6267240. DOI: 10.1007/s11060-018-03015-9. View

Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85(5):365-76. DOI: 10.1093/jnci/85.5.365. View

Thurin E, Nystrom P, Smits A, Werlenius K, Back A, Liljegren A . Proton therapy for low-grade gliomas in adults: A systematic review. Clin Neurol Neurosurg. 2018; 174:233-238. DOI: 10.1016/j.clineuro.2018.08.003. View

Basch E, Barbera L, Kerrigan C, Velikova G . Implementation of Patient-Reported Outcomes in Routine Medical Care. Am Soc Clin Oncol Educ Book. 2018; 38:122-134. DOI: 10.1200/EDBK_200383. View

Ostrom Q, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C . CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. Neuro Oncol. 2019; 21(Suppl 5):v1-v100. PMC: 6823730. DOI: 10.1093/neuonc/noz150. View

Kvale E, Murthy R, Taylor R, Lee J, Nabors L . Distress and quality of life in primary high-grade brain tumor patients. Support Care Cancer. 2009; 17(7):793-9. DOI: 10.1007/s00520-008-0551-9. View

10.

Otto-Meyer S, Lumibao J, Kim E, Ladomersky E, Zhai L, Lauing K . The interplay among psychological distress, the immune system, and brain tumor patient outcomes. Curr Opin Behav Sci. 2019; 28:44-50. PMC: 6487487. DOI: 10.1016/j.cobeha.2019.01.009. View

11.

Kroeze S, Mackeprang P, De Angelis C, Pica A, Bachtiary B, Kliebsch U . A Prospective Study on Health-Related Quality of Life and Patient-Reported Outcomes in Adult Brain Tumor Patients Treated with Pencil Beam Scanning Proton Therapy. Cancers (Basel). 2021; 13(19). PMC: 8507714. DOI: 10.3390/cancers13194892. View

12.

Randazzo D, McSherry F, Herndon 2nd J, Affronti M, Lipp E, Flahiff C . A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor population. J Neurooncol. 2017; 134(2):363-369. DOI: 10.1007/s11060-017-2535-4. View

13.

Haldbo-Classen L, Amidi A, Lukacova S, Wu L, Von Oettingen G, Lassen-Ramshad Y . Cognitive impairment following radiation to hippocampus and other brain structures in adults with primary brain tumours. Radiother Oncol. 2020; 148:1-7. DOI: 10.1016/j.radonc.2020.03.023. View

14.

Vacher E, Rodriguez Ruiz M, Rees J . Management of brain tumour related epilepsy (BTRE): a narrative review and therapy recommendations. Br J Neurosurg. 2023; 39(1):4-11. DOI: 10.1080/02688697.2023.2170326. View

15.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

16.

Thakkar P, Greenwald B, Patel P . Rehabilitation of Adult Patients with Primary Brain Tumors: A Narrative Review. Brain Sci. 2020; 10(8). PMC: 7464729. DOI: 10.3390/brainsci10080492. View

17.

LaPointe S, Perry A, Butowski N . Primary brain tumours in adults. Lancet. 2018; 392(10145):432-446. DOI: 10.1016/S0140-6736(18)30990-5. View

18.

Armstrong T, Vera-Bolanos E, Acquaye A, Gilbert M, Ladha H, Mendoza T . The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptoms. Neuro Oncol. 2015; 18(2):252-60. PMC: 4724180. DOI: 10.1093/neuonc/nov166. View

19.

van der Weide H, Kramer M, Scandurra D, Eekers D, Klaver Y, Wiggenraad R . Proton therapy for selected low grade glioma patients in the Netherlands. Radiother Oncol. 2020; 154:283-290. DOI: 10.1016/j.radonc.2020.11.004. View

20.

Mair M, Geurts M, van den Bent M, Berghoff A . A basic review on systemic treatment options in WHO grade II-III gliomas. Cancer Treat Rev. 2020; 92:102124. DOI: 10.1016/j.ctrv.2020.102124. View